Back to trial
Eligibility Pre-Screening
Leveraging Chimeric Antigen Receptor-Expressing T Cells for Children with Diffuse Midline Glioma
This is a simplified pre-screening tool. Your answers help estimate whether you might qualify, but only the research team can confirm your eligibility. This is not medical advice.
No screening questionnaire available for this trial.